MacroGenics | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Biogen USD 7.63B 169.2M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Daiichi Sankyo JPY 1.91T 66.22B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Genmab DKK 4.04B 23.82B 2025-03
Geron USD 495.77M 4.78M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
J&J USD 71.55B 15.66B 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 35.5B 3.28B 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Xencor USD 521.27M 56.33M 2025-03



MacroGenics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.